A Clinical trial on Thirikandagathi kiyaazham in the management of Azhal Neerchurukku(Urinary Tract Infection)

Assessment of effectiveness of Thirikandagathi kiyaazham in treating Azhal neerchurukku( Urinary tract infection) among patients attending opd, Government Siddha Medical College and Hospital Palayamkottai- A case series - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/069808

Enrollment

Registered

2024-07-02

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Thirikandagathi kiyaazham: DOSAGE:50ml Twice a day orally for 10 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with symptoms of dysuria 2.Frequency of urination 3.Urgency of urination 4.Hematuria 5.Low Back pain 6.Fever(below 103°F) 7.Urine culture positive

Exclusion criteria

Exclusion criteria: 1.Chronic kidney disease 2.Autoimmune glomerulonephritis 3.Benign prostrate hypertrophy 4.Renal calculi 5.Pregnancy & lactating women

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of Azhal Neerchurukku-Urinary Tract Infection(Frequency of urination, Urgency of urination, Hematuria, Low back pain) and to determine the therapeutic efficacy of clinical trial drug(Thirikandagathi kiyaazham)Timepoint: 10 days	—

Secondary

Measure	Time frame
The seconday outcome will be aimed at reducing less than 1,00,000CFU/ml in urine cultureTimepoint: 10 days	—

Countries

India

Contacts

Public ContactProf Dr T Komalavalli Alias Mehala

Government Siddha Medical College and Hospital

komalaarumugam1@gmail.com9788122691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026